RXII
GALENA BIOPHARMA INC COM
RXII
RXII
Delisted
RXII was delisted on the 25th of October, 2011.
73 hedge funds and large institutions have $40.5M invested in GALENA BIOPHARMA INC COM in 2013 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
22% more funds holding
Funds holding: 60 → 73 (+13)
Holders
73
Holding in Top 10
–
Calls
$4.13M
Puts
$3.2M
Top Buyers
| 1 | +$1.98M | |
| 2 | +$1.82M | |
| 3 | +$1.8M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.71M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.23M |
Top Sellers
| 1 | -$957K | |
| 2 | -$800K | |
| 3 | -$771K | |
| 4 |
Goldman Sachs
New York
|
-$495K |
| 5 |
JPMorgan Chase & Co
New York
|
-$164K |